European Journal of Molecular & Clinical Medicine

Background:There is an increase of risk of coronary artery disease about 4-fold with diabetes
mellitus, and ischemic heart disease is liable for diabetes-related deaths. In this study, we
examined the association between glycemic control, as determined by Hemoglobin A1c, and the
incidence of periprocedural complications in diabetic patients who had coronary artery bypass
graft (CABG) undergoing percutaneous coronary intervention (PCI).
Aim of the study:To assess the effect of control of DM on the outcome of PCI in patients who
underwent CABG.

Background:Coronary artery disease is higher in risk with diabetes mellitus, and diabetesrelated
deaths can lead to ischemic heart disease. We examined the relationship between the
glycemic regulation as determined by Hemoglobin A1c and the occurrence of periprocedural
complications in patients who performed percutaneous coronary intervention (PCI) and had
Coronary artery Bypass Graft (CABG)
Objective: To identify associated complications and their sites with Percutaneous Coronary
Intervention in diabetic patientswho performed Coronary Artery Bypass Graft.
Methods:The cross-sectional analysis was performed at the cardiology department in Zagazig
University Hospital in which all 24 CABG & DM patients were included during the period
between January 2019 and January 2020 divided into 12 patients with controlled
DM(HbA1c>7)&12 patients with uncontrolled DM (HbA1c<7).Both patients had a complete
medical history, a detailed clinical evaluation, and preoperative laboratory work: role of the
renal, completion of blood counts as a marker for regulation of DM, ECG, and ECHO.
Glycosylated Hemoglobin HbA1c was used.